Beta Bionics

United States - Irvine, CA

• 04/09/2023
• Series D
• $100,000,000

Beta Bionics is a medical technology company focused on the design, development, and commercialization of the iLet Bionic Pancreas and the bihormonal configuration. The iLet is the first and only insulin delivery system that does not require carb counting*, bolusing, correction factors, or pre-set basal rates. The only number needed to get started with the iLet Bionic Pancreas is a user’s weight – the iLet does the rest. The iLet lets users “Go Bionic” with their diabetes management.

Beta Bionics is a for-profit, public benefit corporation and Certified B Corporation. Since its founding in 2015, its mission has been to help improve health outcomes and the quality of life of children and adults living with diabetes and other conditions of glycemic dysregulation.

*Users must be carb aware.

Related People

Sean SaintFounder

United States - San Diego, California

I’m an entrepreneur, executive and engineer with a proven track record of efficient, innovative product development. I believe it is better to move than to stand still. It is better to trust than to micro-manage. And it is better to forge a new path than to follow blindly.

I was an R&D Director for a leading diabetes medical device company when I was diagnosed with Type I diabetes in 2011. I am deeply committed to our mission of creating tools, software and devices for people living with diabetes that improve outcomes, reduce disruption and increase freedom.

It is always possible to move faster, if we understand the challenges we seek to solve and ask the right questions, the optimal path forward is often clear. It is this philosophy that drives our team to create best-in-class solutions, quickly.

LinkedIn https://www.linkedin.com/in/seansaint1/